Scanbase

Scanbase discovered genuine demand when medical companies began requesting their API unprompted after seeing early demos. Rather than relying on survey responses about interest in diagnostic automation, the team tracked actual API calls and integration attempts. Within months, they measured concrete behavioral signals: clinics were uploading test images at scale, with usage patterns revealing which test types drove the highest volume. Early traction came from urgent care centers and telehealth platforms actively integrating the API into their workflows, not just expressing interest. The strongest validation arrived when customers started requesting support for additional test types—RSV, STD panels, and flu tests—proving they'd moved beyond trial to production use. Revenue growth and expanding customer retention demonstrated that medical companies weren't just testing the concept; they were building their operations around Scanbase's technology. These usage metrics and expansion requests provided far more compelling evidence of demand than any stated interest ever could.